These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35043771)

  • 21. MULTIPLE SCLEROSIS - RISK FACTORS.
    Adamczyk-Sowa M; Gębka-Kępińska B; Kępiński M
    Wiad Lek; 2020; 73(12 cz 1):2677-2682. PubMed ID: 33577489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.
    O'Gorman C; Lucas R; Taylor B
    Int J Mol Sci; 2012; 13(9):11718-11752. PubMed ID: 23109880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses.
    Brütting C; Stangl GI; Staege MS
    J Integr Neurosci; 2021 Mar; 20(1):233-238. PubMed ID: 33834708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.
    Tarlinton RE; Khaibullin T; Granatov E; Martynova E; Rizvanov A; Khaiboullina S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein-Barr virus infection, and vitamin D.
    Latifi T; Zebardast A; Marashi SM
    Mult Scler Relat Disord; 2022 Jan; 57():103318. PubMed ID: 35158423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
    Niller HH; Wolf H; Minarovits J
    Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP
    Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients.
    Celarain N; Tomas-Roig J
    J Neuroinflammation; 2020 Jan; 17(1):21. PubMed ID: 31937331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
    Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
    Front Immunol; 2021; 12():757302. PubMed ID: 34790199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-specific environmental influences affecting MS development.
    Correale J; Balbuena Aguirre ME; Farez MF
    Clin Immunol; 2013 Nov; 149(2):176-81. PubMed ID: 23498776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epigenetics' implication in autism spectrum disorders: A review].
    Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
    Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.
    Correale J; Gaitán MI
    Acta Neurol Scand; 2015; 132(199):46-55. PubMed ID: 26046559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
    Woellmer A; Arteaga-Salas JM; Hammerschmidt W
    PLoS Pathog; 2012 Sep; 8(9):e1002902. PubMed ID: 22969425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and Pathophysiology of Multiple Sclerosis.
    Ward M; Goldman MD
    Continuum (Minneap Minn); 2022 Aug; 28(4):988-1005. PubMed ID: 35938654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics regulation during virus-host interaction and their effects on the virus and host cell.
    Rehman UU; Ghafoor D; Ullah A; Ahmad R; Hanif S
    Microb Pathog; 2023 Sep; 182():106271. PubMed ID: 37517745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies.
    Vandebergh M; Degryse N; Dubois B; Goris A
    J Neurol; 2022 Aug; 269(8):4565-4574. PubMed ID: 35366084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of multiple sclerosis-related genes regulated by EBV-encoded microRNAs in B cells.
    Rang X; Liu Y; Wang J; Wang Y; Xu C; Fu J
    Mult Scler Relat Disord; 2022 Mar; 59():103563. PubMed ID: 35114606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis.
    Afrasiabi A; Parnell GP; Swaminathan S; Stewart GJ; Booth DR
    Sci Rep; 2020 Jan; 10(1):193. PubMed ID: 31932685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
    Huynh JL; Casaccia P
    Lancet Neurol; 2013 Feb; 12(2):195-206. PubMed ID: 23332363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.